Relmada Therapeutics Inc.
(RLMD) ✕
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
undefined
undefined%
At close: undefined
0.49
1.08%
Pre-market Jan 08, 2025, 05:55 AM EST
Ratios (Annual)
Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
PE Ratio | -1.26 | -0.66 | -3.14 | -8.41 | -23.99 | -2.65 | -1.41 | -1.57 | -8.89 | -4.85 | -1.27K | -7.09K |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 11.11K | 10.77K |
PB Ratio | 1.46 | 0.74 | 1.90 | 4.74 | 3.11 | 6.04 | -2.3 | 6.78 | 3.76 | 11.45 | -1.03 | 7.53K |
P/FCF Ratio | -2.41 | -1 | -4.3 | -17.98 | -29.76K | -4.38 | -2.11 | -1.52 | -1.93 | -6.21 | -4.17K | -11.30K |
P/OCF Ratio | -2.41 | -1 | -4.3 | -17.98 | -29.76K | -4.38 | -2.11 | -1.53 | -2.01 | -6.22 | -4.81K | -11.30K |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -2.31 | -0.95 |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | 0.00 | 0.05 | -0.53 | 0.19 | 0.04 | 0.03 | -0.00 | n/a |
Quick Ratio | 8.00 | 11.94 | 14.08 | 9.30 | 80.21 | 3.65 | 0.39 | 1.45 | 2.86 | 1.45 | 0.96 | 1.71 |
Current Ratio | 8.00 | 12.26 | 14.83 | 9.37 | 80.21 | 3.83 | 0.46 | 1.80 | 3.04 | 1.54 | 0.96 | 2.62 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.43 |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a | -5.17 | -13.13K | n/a | -3.47K | n/a | n/a |
Return on Equity (ROE) | -1.16 | -1.12 | -0.6 | -0.56 | -0.13 | -2.27 | 1.63 | -4.3 | -0.42 | -2.36 | 0.00 | -1.06 |
Return on Assets (ROA) | -1.01 | -1.03 | -0.56 | -0.5 | -0.13 | -1.69 | -2.94 | -2.22 | -0.29 | -0.85 | -0.00 | -0.66 |
Return on Capital (ROIC) | -1.21 | -1.15 | -0.6 | -0.58 | -0.13 | -1.67 | 2.42 | -4.94 | -2.26 | -1.94 | 0.04 | -1.06 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 21.31% | 26.97% |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -877.66% | -151.77% |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -877.66% | -151.77% |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -877.66% | -151.77% |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -266.31% | -95.27% |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -877.66% | -147.02% |